The company’s Genesis 200 Second Harmonic Generation/Two-Photon Excitation imaging system is used in the development of drugs to treat nonalcoholic steatohepatitis, according to an April 10 HistoIndex news release.
The health system will work with the Singapore-based medtech company to get FDA approval for its imaging system.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
